Retinal basement membrane abnormalities and the retinopathy of Alport syndrome

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 3, 2010, Pages 1621-1627

  Savige, Judy ^a   Liu, John ^a   DeBuc, Delia Cabrera ^b   Handa, James T ^c   Hageman, Gregory S ^d   Wang, Yan Yan ^a   Parkin, John D ^a   Vote, Brendan ^e   Fassett, Rob ^e   Sarks, Shirley ^a   Colville, Deb ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e LAUNCESTON GENERAL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; AUTOANTIGEN; COL4A5 PROTEIN, HUMAN; TYPE IV COLLAGEN ALPHA3 CHAIN;

ADOLESCENT; ADULT; AGED; ALPORT SYNDROME; ANATOMICAL VARIATION; ARTICLE; BASEMENT MEMBRANE; BRUCH MEMBRANE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EYE PHOTOGRAPHY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MULTICENTER STUDY; NERVE FIBER; OPTICAL COHERENCE TOMOGRAPHY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA BIPOLAR GANGLION CELL; RETINA MACULA HOLE; RETINOPATHY; CLINICAL TRIAL; ENZYME IMMUNOASSAY; GENETIC LINKAGE; METABOLISM; MIDDLE AGED; NEPHRITIS; PATHOLOGY; RETINA; RETINA DISEASE; ULTRASTRUCTURE;

ADOLESCENT; ADULT; AGED; AUTOANTIGENS; BASEMENT MEMBRANE; BRUCH MEMBRANE; COLLAGEN TYPE IV; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LINKAGE (GENETICS); MALE; MIDDLE AGED; NEPHRITIS, HEREDITARY; NERVE FIBERS; RETINA; RETINAL DISEASES; RETINAL PIGMENT EPITHELIUM; TOMOGRAPHY, OPTICAL COHERENCE; YOUNG ADULT;

EID: 77949889531     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-3323     Document Type: Article

References (33)

1. Levy M, Feingold J. Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int. 2000;58:925-943.
2. Gubler M, Levy M, Broyer M, et al. Alport's syndrome: a report of 58 cases and a review of the literature. Am J Med. 1981;70:493-505.
3. Feingold J, Bois E, Chompret A, Broyer M, Gubler M-C, Grunfeld J-P. Genetic heterogeneity of Alport syndrome. Kidney Int. 1985; 27:672-677.
4. Barker DF, Hostikka SL, Zhou J, et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science. 1990;248: 1224-1227.
5. Mochizuki T, Lemmink HH, Mariyama M, et al. Identification of mutations in the alpha3(IV) and alpha 4(IV) collagen gene in autosomal recessive Alport syndrome. Nat Genet. 1994;8:77-81.
6. Yoshioka K, Hino S, Takemura T, et al. Type IV collagen α5 chain: normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol. 1994;44:986-996.
7. Rumpelt HJ, Langer KH, Scharer K, Straub E, Thoenes W. Split and extremely thin glomerular basement membranes in hereditary nephritis (Alport's syndrome). Virchows Arch A Pathol Anat Histol. 1974;364:225-233.
8. Arnold W. Uberlegungen zur pathogenese des cochleo-renalen syndroms. Acta Otolaryngol. 1980;89:330-341.
9. Streeten BW, Robinson MR, Wallace R, Jones BD. Lens capsule in Alport's syndrome. Arch Ophthalmol. 1987;105:1693-1697.
10. Arnott EJ, Crawfurd MD'A, Toghill PJ. Anterior lenticonus and Alport's syndrome. Br J Ophthalmol. 1966;50:390-403.
11. Polak BCP, Hogewind BL. Macular lesions in Alport's disease. Am J Ophthalmol. 1977;84:532-535.
12. Govan JA. Ocular manifestations of Alport's syndrome: a hereditary disorder of basement membranes? Br J Ophthalmol. 1983;67:493-503.
13. Colville D, Savige JA. Alport syndrome: a review of the ocular manifestations. Ophthalmic Genet. 1997;18:161-173.
14. Gehrs KM, Pollock SC, Zilkha G. Clinical features and pathogenesis of Alport retinopathy. Retina. 1995;15:305-311.
15. Jais JP, Knebelmann B, Giatras I, De Marchi M, et al. X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol. 2000;11:649-657.
16. Jais JP, Knebelmann B, Giatras I, et al. X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and females belonging to 195 families: a 'European Community Alport Syndrome Concerted Action' study. J Am Soc Nephrol. 2003;14: 2603-2610.
17. Dagher H, Buzza M, Colville D, et al. A comparison of the clinical, histopathological and ultrastructural phenotypes in carriers of Xlinked and autosomal recessive Alport syndrome. Am J Kidney Dis. 2001;38:1217-1228.
18. Shaw EA, Colville D, Wang YY, et al. Characterisation of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome. Nephrol Dial Transplant. 2007;22:104-108.
19. Cervantes-Coste G, Fuentes-Paez G, Yeshurun I, Jimenez-Sierra JM. Tapetal-like sheen associated with fleck retinopathy in Alport syndrome. Retina. 2003;23:245-247.
20. Zhang KW, Colville D, Tan R, et al. The use of ocular abnormalities to diagnose X-linked Alport syndrome in children. Pediatr Nephrol. 2008;23(8):1245-1250.
21. Mete UO, Karaaslan C, Ozbilgin MK, Polar S, Tap O, Kaya M. Alport's syndrome with bilateral macular hole. Acta Ophthalmol Scand. 1996;74:77-80.
22. Rahman W, Banerjee S. Giant macular hole in Alport syndrome. Can J Ophthalmol. 2007;42:314-315.
23. Chen L, Miyamura N, Ninomiya Y, Handa JT. Distribution of the collagen IV isoforms in human Bruch's membrane. Br J Ophthalmol. 2003;87:212-215.
24. Usui T, Ichibe M, Hasegawa S, et al. Symmetrical reduced retinal thickness in a patient with Alport syndrome. Retina. 2004;24:977-979.
25. Cabrera Fernandez D, Salinas HM, Puliafito CA. Automated detection of retinal layer structures on optical coherence images. Opt Express. 2005;13:10200-10216.
26. Russell S, Mullins R, Schneider B, Hageman G. Basal laminar drusen are indistinguishable in location, substructure and composition from drusen associated with ageing and age-related macular degeneration. Am J Ophthalmol. 2002;129:205-214.
27. Taylor SJ. Gunn's dots. Br J Ophthalmol. 1918;2:300.
28. Johnson PT, Lewis GP, Talaga KC, et al. Drusen-associated degeneration in the retina. Invest Ophthalmol Vis Sci. 2003;44:4481-4488.
29. Duvall-Young J, Macdonald MK, McKechnie NM. Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report. Br J Ophthalmol. 1989;73:297-302.
30. Mullins RF, Aptsiauri N, Hageman GS. Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye. 2001;15:390-395.
31. Appel GB, Cook HT, Hageman G, et al. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol. 2005;16:1392-1403.
32. Hood J, Savige JA, Dowling J, et al. Basement membrane abnormalities in autosomal dominant Alport syndrome. Am J Kidney Dis. 2000;113:455-457.
33. Rao VH, Lees GE, Kashtan CE, et al. Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS). Kidney Int. 2003;63:1736-1748.